Recurrence Rates Over 20 Years in the Treatment of Malignant Melanoma: Immediate Versus Delayed Reconstruction

Background:. Wide local excision (WLE) with a safety margin is the standard of treatment for primary head and neck cutaneous malignant melanoma (HNCMM). Studies have demonstrated inconsistency in recurrence rates following immediate versus delayed reconstruction. The objectives of this study were to...

Full description

Bibliographic Details
Main Authors: Pieter G.L. Koolen, MD, Tiago R. Matos, MD, Ahmed M.S. Ibrahim, MD, PhD, Jie Sun, BA, Bernard T. Lee, MD, MBA, MPH, Robert A. Frankenthaler, MD, Samuel J. Lin, MD
Format: Article
Language:English
Published: Wolters Kluwer 2017-07-01
Series:Plastic and Reconstructive Surgery, Global Open
Online Access:http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000001378
_version_ 1811191629843791872
author Pieter G.L. Koolen, MD
Tiago R. Matos, MD
Ahmed M.S. Ibrahim, MD, PhD
Jie Sun, BA
Bernard T. Lee, MD, MBA, MPH
Robert A. Frankenthaler, MD
Samuel J. Lin, MD
author_facet Pieter G.L. Koolen, MD
Tiago R. Matos, MD
Ahmed M.S. Ibrahim, MD, PhD
Jie Sun, BA
Bernard T. Lee, MD, MBA, MPH
Robert A. Frankenthaler, MD
Samuel J. Lin, MD
author_sort Pieter G.L. Koolen, MD
collection DOAJ
description Background:. Wide local excision (WLE) with a safety margin is the standard of treatment for primary head and neck cutaneous malignant melanoma (HNCMM). Studies have demonstrated inconsistency in recurrence rates following immediate versus delayed reconstruction. The objectives of this study were to assess and compare recurrence rates after WLE of HNCMM followed by immediate or delayed reconstruction in determining recurrence-free survival estimates. Methods:. A consecutive, retrospective analysis of 451 patients undergoing WLE of primary HNCMM followed by reconstruction over a period of 20 years was performed. Patients were divided into 2 groups based on timing of reconstruction (immediate versus delayed). Univariate analyses were performed to assess distributions. Kaplan–Meier survival analysis and multivariate Cox proportional hazard analyses were performed to estimate recurrence-free survival. Results:. Tumor specimen positive margins were comparable between immediate and delayed reconstruction groups (P = 0.129). Univariate analysis demonstrated comparable local melanoma recurrence after immediate or delayed reconstruction (41.4% versus 53.3%; P = 0.399). After adjusting for prognostic factors, multivariate analysis also failed to demonstrate an association between reconstruction timing and local recurrence-free survival (P = 0.167). Conclusions:. In this long-term study, we were not able to demonstrate an association between reconstruction timing and local recurrence-free survival after excision WLE of HNCMM, rendering immediate reconstruction a reliable approach. In addition, the presence of ulceration and a positive sentinel lymph node were positively associated with the risk of recurrence.
first_indexed 2024-04-11T23:39:04Z
format Article
id doaj.art-79e3e8d19e4345da819c8f4b01b2f5e1
institution Directory Open Access Journal
issn 2169-7574
language English
last_indexed 2024-04-11T23:39:04Z
publishDate 2017-07-01
publisher Wolters Kluwer
record_format Article
series Plastic and Reconstructive Surgery, Global Open
spelling doaj.art-79e3e8d19e4345da819c8f4b01b2f5e12022-12-22T03:56:50ZengWolters KluwerPlastic and Reconstructive Surgery, Global Open2169-75742017-07-015710.1097/GOX.0000000000001378gox-5-e1378Recurrence Rates Over 20 Years in the Treatment of Malignant Melanoma: Immediate Versus Delayed ReconstructionPieter G.L. Koolen, MD0Tiago R. Matos, MD1Ahmed M.S. Ibrahim, MD, PhD2Jie Sun, BA3Bernard T. Lee, MD, MBA, MPH4Robert A. Frankenthaler, MD5Samuel J. Lin, MD6From the *Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.; †Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.; ‡Harvard School of Dental Medicine, Boston, Mass.; and §Division of Otolaryngology-Head and Neck Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.From the *Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.; †Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.; ‡Harvard School of Dental Medicine, Boston, Mass.; and §Division of Otolaryngology-Head and Neck Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.From the *Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.; †Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.; ‡Harvard School of Dental Medicine, Boston, Mass.; and §Division of Otolaryngology-Head and Neck Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.From the *Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.; †Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.; ‡Harvard School of Dental Medicine, Boston, Mass.; and §Division of Otolaryngology-Head and Neck Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.From the *Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.; †Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.; ‡Harvard School of Dental Medicine, Boston, Mass.; and §Division of Otolaryngology-Head and Neck Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.From the *Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.; †Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.; ‡Harvard School of Dental Medicine, Boston, Mass.; and §Division of Otolaryngology-Head and Neck Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.From the *Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.; †Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.; ‡Harvard School of Dental Medicine, Boston, Mass.; and §Division of Otolaryngology-Head and Neck Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.Background:. Wide local excision (WLE) with a safety margin is the standard of treatment for primary head and neck cutaneous malignant melanoma (HNCMM). Studies have demonstrated inconsistency in recurrence rates following immediate versus delayed reconstruction. The objectives of this study were to assess and compare recurrence rates after WLE of HNCMM followed by immediate or delayed reconstruction in determining recurrence-free survival estimates. Methods:. A consecutive, retrospective analysis of 451 patients undergoing WLE of primary HNCMM followed by reconstruction over a period of 20 years was performed. Patients were divided into 2 groups based on timing of reconstruction (immediate versus delayed). Univariate analyses were performed to assess distributions. Kaplan–Meier survival analysis and multivariate Cox proportional hazard analyses were performed to estimate recurrence-free survival. Results:. Tumor specimen positive margins were comparable between immediate and delayed reconstruction groups (P = 0.129). Univariate analysis demonstrated comparable local melanoma recurrence after immediate or delayed reconstruction (41.4% versus 53.3%; P = 0.399). After adjusting for prognostic factors, multivariate analysis also failed to demonstrate an association between reconstruction timing and local recurrence-free survival (P = 0.167). Conclusions:. In this long-term study, we were not able to demonstrate an association between reconstruction timing and local recurrence-free survival after excision WLE of HNCMM, rendering immediate reconstruction a reliable approach. In addition, the presence of ulceration and a positive sentinel lymph node were positively associated with the risk of recurrence.http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000001378
spellingShingle Pieter G.L. Koolen, MD
Tiago R. Matos, MD
Ahmed M.S. Ibrahim, MD, PhD
Jie Sun, BA
Bernard T. Lee, MD, MBA, MPH
Robert A. Frankenthaler, MD
Samuel J. Lin, MD
Recurrence Rates Over 20 Years in the Treatment of Malignant Melanoma: Immediate Versus Delayed Reconstruction
Plastic and Reconstructive Surgery, Global Open
title Recurrence Rates Over 20 Years in the Treatment of Malignant Melanoma: Immediate Versus Delayed Reconstruction
title_full Recurrence Rates Over 20 Years in the Treatment of Malignant Melanoma: Immediate Versus Delayed Reconstruction
title_fullStr Recurrence Rates Over 20 Years in the Treatment of Malignant Melanoma: Immediate Versus Delayed Reconstruction
title_full_unstemmed Recurrence Rates Over 20 Years in the Treatment of Malignant Melanoma: Immediate Versus Delayed Reconstruction
title_short Recurrence Rates Over 20 Years in the Treatment of Malignant Melanoma: Immediate Versus Delayed Reconstruction
title_sort recurrence rates over 20 years in the treatment of malignant melanoma immediate versus delayed reconstruction
url http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000001378
work_keys_str_mv AT pieterglkoolenmd recurrenceratesover20yearsinthetreatmentofmalignantmelanomaimmediateversusdelayedreconstruction
AT tiagormatosmd recurrenceratesover20yearsinthetreatmentofmalignantmelanomaimmediateversusdelayedreconstruction
AT ahmedmsibrahimmdphd recurrenceratesover20yearsinthetreatmentofmalignantmelanomaimmediateversusdelayedreconstruction
AT jiesunba recurrenceratesover20yearsinthetreatmentofmalignantmelanomaimmediateversusdelayedreconstruction
AT bernardtleemdmbamph recurrenceratesover20yearsinthetreatmentofmalignantmelanomaimmediateversusdelayedreconstruction
AT robertafrankenthalermd recurrenceratesover20yearsinthetreatmentofmalignantmelanomaimmediateversusdelayedreconstruction
AT samueljlinmd recurrenceratesover20yearsinthetreatmentofmalignantmelanomaimmediateversusdelayedreconstruction